[archived webcast] Institutional Review Boards that Oversee Experimental Human Testing for Profit. House Committee on Energy and Commerce Subcommittee on Oversight and Investigations. 2009-03-26: http://preview.tinyurl.com/mgxxc3
[transcript] Institutional Review Boards that Oversee Experimental Human Testing for Profit: http://energycommerce.house.gov/Press_111/20090326/transcript_20090326_oi.pdf
[archived webcast] Ketek Clinical Study Fraud: What Did Aventis Know? House Committee on Energy and Commerce Subcommittee on Oversight and Investigations. 2008-02-12: http://energycommerce.house.gov/cmte_mtgs/110-oi-hrg.021208.Ketek.shtml
[transcript] Serial No.110-87 Ketek Clinical Study Fraud: What did Aventis Know? Hearing Before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce. 110th Congress Second Session. 2008-02-13: http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=110_house_hearings&docid=f:48587.pdf [File size: 5.2M]
Hearing Exhibit Binder: http://energycommerce.house.gov/cmte_mtgs/021208.KetekHearing.ExhibitBinder.shtml
More information about Ketek™: http://www.circare.org/foia5/ketek.htm
Serial No. 110-5. The Adequacy of FDA To Assure the Safety of the Nation's Drug Supply. Hearing Before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce. House of Representatives. 110th Congress First Session. 2007-02-13 and 03-22. Available from http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=110_house_hearings&docid=f:35502.pdf [File size: 7.4M]
Serial No. 105-49. Oversight Of NIH And FDA: Bioethics And The Adequacy Of Informed Consent. Hearing Before the Subcommittee on Human Resources of the Committee on Government Reform and Oversight. House of Representatives. 105th Congress Second Session. May 8, 1997. Available from http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=105_house_hearings&docid=f:44389.pdf [File size: 5080.21k]
Serial No. 105-138. Clinical Trial Subjects: Adequate FDA Protections? Hearing Before the Subcommittee on Human Resources of the Committee on Government Reform and Oversight. House of Representatives. 105th Congress Second Session. April 22, 1998. Available from http://www.access.gpo.gov/congress/house/pdf/105hrg/49827.pdf [File size: 7.5M]
Serial No. 105-66. Institutional Review Boards: A System in Jeopardy. Hearing Before the Subcommittee on Human Resources of the Committee on Government Reform. House of Representatives. 105th Congress Second Session. June 11, 1998. Available from http://www.access.gpo.gov/congress/house/pdf/105hrg/50894.pdf [File size: 6.5M]
Serial No. 106-123. Force Protection: Improving Safeguards for Administration of Investigational New Drugs to Members of the Armed Forces. Hearing Before the Subcommittee on National Security, Veterans Affairs, and International Relations of the Committee on Government Reform. House of Representatives. 106th Congress First Session. 1999-11-09. Available from http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=106_house_hearings&docid=f:64776.pdf [File size: 2M]
Serial No. 106-198. Human Subject Research Protections. Hearing Before the Subcommittee on Criminal Justice, Drug Policy, and Human Resources of the Committee on Government Reform. House of Representatives. May 3, 2000. 106th Congress / Second Session. Available from http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=106_house_hearings&docid=f:70580.pdf [File size: 4702.58k]
S. Hrg. 107-424. Protecting Human Subjects in Research: Are Current Safeguards Adequate? Senate Committee on Health, Education, Labor, and Pensions Committee Hearings. 107th Congress. April 23, 2002. Available from http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=107_senate_hearings&docid=f:79325.pdf [File size: 480k]
Serial No. 105-103. Patient Access to Alternative Treatments: Beyond The FDA. Committee on Government Reform and Oversight. House of Representatives. 105th Congress. February 4 & 12, 1998. Available from http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=105_house_hearings&docid=f:48143.pdf [File size: 12006.19k]
Serial No. 106-33. Cardiovascular Disease: Is The Government Doing More Harm Than Good? Edta Chelation Therapy. Committee on Government Reform and Oversight. House of Representatives. 106th Congress. March 10, 1999. Available from http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=106_house_hearings&docid=f:59973.pdf [File size: 5760.17k]
Serial No. 107-142. An Inquiry into the Imclone Cancer-Drug Story. House Committee on Energy and Commerce Hearing. 107th Congress. June 13 and October 10, 2002. Available from http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=107_house_hearings&docid=f:80678.pdf [File size: 27.2M]
Serial No. 108-38. NIH: Moving Research from the Bench to the Bedside. House Committee on Energy and Commerce Hearing. 108th Congress. July 10, 2003. Available from http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=108_house_hearings&docid=f:88429.pdf [File size: 543k]
Serial No. 108-56. Managing Biomedical Research to Prevent and Cure Disease in the 21st Century: Matching NIH Policy with Science. House Committee on Energy and Commerce Hearing. 108th Congress. October 2, 2003. Available from http://www.access.gpo.gov/congress/house/pdf/108hrg/89964.pdf [File size: 10.9M]
S. Hrg. 108-378. Federal and State Role in Pharmacy Compounding and Reconstruction: Exploring the Right Mix to Protect Patients. Senate Committee on Health, Education, Labor, and Pensions Committee Hearings. 108th Congress / First Session. October 23, 2003. Available from http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=108_senate_hearings&docid=f:90129.pdf [File size: 1.5M]
Serial No. 108-69. NIH: Re-Engineering Clinical Research. House Committee on Energy and Commerce Hearing. 108th Congress. March 25, 2004. Available from http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=108_house_hearings&docid=f:93301.pdf [File size: 364k]
Serial No. 108-88. NIH Ethics Concerns: Consulting Arrangements and Outside Awards. House Committee on Energy and Commerce Hearing. 108th Congress. May 12, May 18, and June 22, 2004. Available from http://www.access.gpo.gov/congress/house/pdf/108hrg/93973.pdf [File size: 25M]
Serial No. 108-121. Publication and Disclosure Issues in Antidepressant Pediatric Clinical Trials. House Committee on Energy and Commerce Hearing. 108th Congress. September 9, 2004. Available from http://www.access.gpo.gov/congress/house/pdf/108hrg/96094.pdf [File size: 25M]
Serial No. 108-125. FDA's Role in Protecting the Public Health: Examining FDA's Review of Safety and Efficacy Concerns in Anti-Depressant Use by Children. House Committee on Energy and Commerce Hearing. 108th Congress First Session. September 23, 2004. Available from http://www.access.gpo.gov/congress/house/pdf/108hrg/96099.pdf [File size: 21.8M]
Serial No. 108-131. Scientific Opportunities and Public Needs: Balancing NIH's Priority Setting Process. House Committee on Energy and Commerce Hearing. 108th Congress. June 2, 2004. Available from http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=108_house_hearings&docid=f:95440.pdf [File size: 1.6M]
S. Hrg. 105-686. National Cancer Institute's Management of Radiation Studies. Senate Committee on Homeland Security and Governmental Affairs. 105th Congress. 1998-09-16. Available from http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=105_senate_hearings&docid=f:51644.pdf
S. Hrg.107-190. Swindlers, Hucksters and Snake Oil Salesmen: The Hype and Hope of Marketing Anti-Aging Products to Seniors. Senate Special Committee on Aging. 107th Congress. 2001-09-21. Available from http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=107_senate_hearings&docid=f:76011.pdf
Serial No. 106-180. Autism: Present Challenges, Future Needs — Why the Increased Rates? Committee on Government Reform and Oversight. House of Representatives. 106th Congress Second Session. April 6, 2000. Available from http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=106_house_hearings&docid=f:69622.pdf [File size: 17.3M]
Serial No. 106-232. Mercury in Medicine — Are We Taking Unnecessary Risks? Committee on Government Reform and Oversight. House of Representatives. 106th Congress Second Session. July 18, 2000. Available from http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=106_house_hearings&docid=f:72722.pdf [File size: 32M]
Serial No. 107-29. Autism — Why the Increased Rates? A One-Year Update. Committee on Government Reform and Oversight. House of Representatives. 107th Congress First Session. April 25 and 26, 2001. Available from http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=107_house_hearings&docid=f:76856.pdf [File size: 10.5M]
Serial No. 107-74. The Autism Epidemic — Is the NIH and CDC Response Adequate? Committee on Government Reform and Oversight. House of Representatives. 107th Congress Second Session. April 18, 2002. Available from http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=107_house_hearings&docid=f:80356.pdf [File size: 4.1M]
Serial No. 107-121. The Status of Research into Vaccine Safety and Autism. Committee on Government Reform and Oversight. House of Representatives. 107th Congress Second Session. June 19, 2002. Available from http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=107_house_hearings&docid=f:82358.pdf [File size: 16.2M]
Serial No. 107-153. Vaccines and the Autism Epidemic: Reviewing the Federal Government's Track Record and Charting a Course for the Future. Committee on Government Reform and Oversight. House of Representatives. 107th Congress Second Session. December 10, 2002. Available from http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=107_house_hearings&docid=f:84605.pdf [File size: 15M]
Serial No. 108-125. The Future Challenges of Autism: A Survey of the Ongoing Initiatives in the Federal Government to Address the Epidemic. Committee on Government Reform and Oversight. House of Representatives. 108th Congress First Session. November 20, 2003. Available from http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=108_house_hearings&docid=f:92727.pdf [File size: 1.5M]
Serial No. 108-192. Autism Spectrum Disorders: An Update of Federal Government Initiatives and Revolutionary New Treatment of Neuro-Developmental Diseases. Committee on Government Reform and Oversight. House of Representatives. 108th Congress Second Session. May 6, 2004. Available from http://www.access.gpo.gov/congress/house/pdf/108hrg/95740.pdf [File size: 4.6M]
Serial No. 108-262. Truth Revealed: New Scientific Discoveries Regarding Mercury in Medicine and Autism. Committee on Government Reform and Oversight. House of Representatives. 108th Congress Second Session. September 8, 2004. Available from http://www.access.gpo.gov/congress/house/pdf/108hrg/98046.pdf [File size: 14M]
Last Updated: 2009-08-01
If you find the information on this page helpful please support CIRCARE with a tax-deductible contribution today. Because CIRCARE doesn't accept funds from pharmaceutical or medical device manufacturers, we depend on contributions from individuals like you to help us advocate for meaningful protection of human subjects in research. Donating online with PayPal is quick and easy. Find out more on our Support page
All material on this site © CIRCARE Incorporated (2002- ) or as indicated. Single copies can be downloaded for personal education. Adobe® Reader :: ::
